glp 1 neurological effects GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight Role of glucagon-like peptide-1 receptor

The American Diabetes Association (ADA) recommends GLP-1 receptor agonists with proven cardiovascular benefit as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk

Tirzepatide-induced gastrointestinal manifestations: A systematic review and meta-analysis

PMID 40123442

Single-cell capturing, isolation of mRNA, and synthesis of cDNA used the BD Rhapsody Single-Cell Analysis System

GLP-1 medications have become widely available online, but patients are frequently met with confusing pricing structures, unrealistic expectations, and little to no support once treatment begins

Wren et al., 2000)